vs

Side-by-side financial comparison of Baxter International (BAX) and Clorox (CLX). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($4.8B vs $2.7B, roughly 1.8× Baxter International). On growth, Baxter International posted the faster year-over-year revenue change (3.0% vs -6.7%). Clorox produced more free cash flow last quarter ($637.0M vs $76.0M). Over the past eight quarters, Clorox's revenue compounded faster (62.2% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

BAX vs CLX — Head-to-Head

Bigger by revenue
CLX
CLX
1.8× larger
CLX
$4.8B
$2.7B
BAX
Growing faster (revenue YoY)
BAX
BAX
+9.7% gap
BAX
3.0%
-6.7%
CLX
More free cash flow
CLX
CLX
$561.0M more FCF
CLX
$637.0M
$76.0M
BAX
Faster 2-yr revenue CAGR
CLX
CLX
Annualised
CLX
62.2%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
BAX
BAX
CLX
CLX
Revenue
$2.7B
$4.8B
Net Profit
$-15.0M
Gross Margin
33.0%
Operating Margin
2.4%
Net Margin
-0.6%
Revenue YoY
3.0%
-6.7%
Net Profit YoY
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
CLX
CLX
Q1 26
$2.7B
$4.8B
Q4 25
$3.0B
$1.7B
Q3 25
$2.8B
Q2 25
$2.8B
$2.0B
Q1 25
$2.6B
$1.7B
Q4 24
$533.0M
$1.7B
Q3 24
$2.7B
$1.8B
Q2 24
$3.8B
$1.9B
Net Profit
BAX
BAX
CLX
CLX
Q1 26
$-15.0M
Q4 25
$-1.1B
$157.0M
Q3 25
$-46.0M
Q2 25
$91.0M
$332.0M
Q1 25
$126.0M
$186.0M
Q4 24
$-512.0M
$193.0M
Q3 24
$140.0M
$99.0M
Q2 24
$-314.0M
$216.0M
Gross Margin
BAX
BAX
CLX
CLX
Q1 26
33.0%
Q4 25
19.4%
43.2%
Q3 25
33.5%
Q2 25
35.3%
46.5%
Q1 25
32.8%
44.6%
Q4 24
25.0%
43.8%
Q3 24
38.3%
45.8%
Q2 24
37.5%
46.5%
Operating Margin
BAX
BAX
CLX
CLX
Q1 26
2.4%
Q4 25
-24.5%
Q3 25
6.1%
Q2 25
6.8%
20.6%
Q1 25
2.2%
15.2%
Q4 24
-25.5%
14.1%
Q3 24
5.7%
10.0%
Q2 24
-5.0%
14.5%
Net Margin
BAX
BAX
CLX
CLX
Q1 26
-0.6%
Q4 25
-37.9%
9.4%
Q3 25
-1.6%
Q2 25
3.2%
16.7%
Q1 25
4.8%
11.2%
Q4 24
-96.1%
11.4%
Q3 24
5.2%
5.6%
Q2 24
-8.2%
11.4%
EPS (diluted)
BAX
BAX
CLX
CLX
Q1 26
$-0.03
Q4 25
$-2.21
$1.29
Q3 25
$-0.09
Q2 25
$0.18
$2.68
Q1 25
$0.25
$1.50
Q4 24
$-0.99
$1.54
Q3 24
$0.27
$0.80
Q2 24
$-0.62
$1.74

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
CLX
CLX
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$76.0M
$637.0M
FCF MarginFCF / Revenue
2.8%
13.3%
Capex IntensityCapex / Revenue
5.1%
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
CLX
CLX
Q1 26
Q4 25
$584.0M
Q3 25
$237.0M
Q2 25
$217.0M
$294.0M
Q1 25
$-193.0M
$286.0M
Q4 24
$488.0M
$180.0M
Q3 24
$253.0M
$221.0M
Q2 24
$115.0M
$340.0M
Free Cash Flow
BAX
BAX
CLX
CLX
Q1 26
$76.0M
$637.0M
Q4 25
Q3 25
Q2 25
$219.0M
Q1 25
$233.0M
Q4 24
$127.0M
Q3 24
$182.0M
Q2 24
$259.0M
FCF Margin
BAX
BAX
CLX
CLX
Q1 26
2.8%
13.3%
Q4 25
Q3 25
Q2 25
11.0%
Q1 25
14.0%
Q4 24
7.5%
Q3 24
10.3%
Q2 24
13.6%
Capex Intensity
BAX
BAX
CLX
CLX
Q1 26
5.1%
2.5%
Q4 25
Q3 25
Q2 25
3.8%
Q1 25
3.2%
Q4 24
3.1%
Q3 24
2.2%
Q2 24
4.3%
Cash Conversion
BAX
BAX
CLX
CLX
Q1 26
Q4 25
Q3 25
Q2 25
2.38×
0.89×
Q1 25
-1.53×
1.54×
Q4 24
0.93×
Q3 24
1.81×
2.23×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons